Recalled Diamond Shruumz Linked to Three Deaths, 175 Illnesses, FDA Reports
FDA has identified traces of schedule I controlled substances, prescription drugs and other potentially harmful ingredients in recalled Diamond Shruumz microdosing edibles.
October 07, 2024 By: Martha Garcia
FDA has identified traces of schedule I controlled substances, prescription drugs and other potentially harmful ingredients in recalled Diamond Shruumz microdosing edibles.
Birth control shot manufacturer supports the consolidation of Depo-Provera brain tumor lawsuits, but argues that the claims should be centralized in the Southern District of New York, where the company is headquartered.
A growing number of lawsuits describe severe and painful symptoms experienced after a Cartiva toe implant failed, alleging that the manufacturer knew or should have known about the risks.
A group of four BioZorb lawsuits have been selected for early bellwether trials, which are expected to begin in September 2025.
"*" indicates required fields